What was claimed
76-year-old woman with Stage 3 breast cancer became cancer-free in 3 months using Ivermectin (1mg/kg/day), Fenbendazole (1332mg/day), and Letrozole. Earlier use of these repurposed drugs leads to higher success; critics of Ivermectin for cancer are on payroll or frauds.
Our verdict
InaccurateThere is no clinical evidence that early use of ivermectin or fenbendazole improves cancer outcomes, and major cancer organizations explicitly state there is no proven benefit of ivermectin or fenbendazole as cancer treatments. Existing data are largely preclinical and limited early-phase trials and do not establish timing-related success in humans. American Cancer Society and oncology experts state ivermectin is not approved for any cancer and has no proven benefit as a cancer treatment, with evidence limited to lab and early-phase studies. Current clinical trials in metastatic triple-negative breast cancer show limited and mixed results and do not establish ivermectin as a curative therapy.
Check your own claim
Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.
Key findings
Earlier use of these repurposed drugs leads to higher success (in cancer).
Ivermectin is a proven treatment that can make breast cancer patients cancer-free in three months.
Fenbendazole is a proven cancer treatment for humans.
At this time, there is strong human clinical evidence supporting ivermectin as a chemotherapeutic agent in breast cancer.
Letrozole is part of this repurposed drug protocol
Stage 3 breast cancer can achieve remission in 3 months with these repurposed drugs alone
A 76-year-old woman became cancer-free in 3 months using these drugs
A 76-year-old woman with Stage 3 breast cancer became cancer-free in 3 months using Ivermectin (1 mg/kg/day), Fenbendazole (1332 mg/day), and Letrozole.
Critics of Ivermectin for cancer are on payroll or frauds.